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to investigate how the dietary selenium supplementation to influence the gene 
expression of p38, p65, and caspase-3 in fluorosis patients. Methods: Ziyang 
County of Ankang City has higher environmental selenium level, while fluorosis 
patients who lived in have the habit of tea drinking, especially in Haoping Town. 
Hanbin district of Ankang City has lower environmental selenium level was choose 
as selenium internal control. The fluorosis patients from different environmental 
selenium level area and the healthy volunteer were divided into three groups: 
“High Se + F group” (n= 20), “High F group” (n= 20) and “Control group” (n= 20). p38, 
NF-kB p65 and caspase-3 mRNA level were examined by RT-PCR. β -actin served 
as determining control The concentration of fluoride in serum and urine, the con-
tent of Se in hair were also determined. Results: The concentration of fluorine 
in “High F group” and “High Se + F group” in serum and urine was higher than 
that in “Control group” (urine 3.2731±0.26, 3.2744±0.31 and 0.7923±0.14, respec-
tively; serum: 0.3996±0.03, 0.3888±0.09, 0.0922±0.01, respectively). The mean for 
total Se concentration in hair was different: 2.5005±0.27 in “High Se + F group”, 
0.6075±0.07 in “High F group” and 0.5215±0.05 in “Control group”, respectively. 
The mRNA level of p38, NF-kB p65 and caspase-3 was significantly high in “High 
F group” than that in “High Se + F group” and “Control group” (p38:5.0009±0.65, 
1.2749±0.09, 1.0574±0.13, respectively; NF-kB p65: 3.5248±0.47, 1.9845±0.14, 
1.9976±0.15, respectively; caspase-3:2.2936±0.23, 1.2841±0.19, 1.3590±0.18, respec-
tively). ConClusions: These results suggest that dietary high selenium intake 
help people who suffering fluorosis lessen damage by reduce the gene expres-
sion of p38, then reduce NF-kB p65 gene expression and at last lower the gene 
expression of caspase-3.
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objeCtives: Gridhrasi(Sciatica Syndrome), Lumbar disc lesions are responsible 
for the disorder and observed about 25% loss of work, affects social and eco-
nomic position of the individual and family. The Alopathy treatment involves 
symptomatic treatments medicines by analgesics for prolonged time associated 
with more serious and irreversible reaction. Here we have tested a traditional 
approach as per principles of Ayurveda. Methods: The study was conducted in 
the OPD and IPD of MIAMS, Manipal with 3 trial groups A-Trayodashangaguggulu, 
B-Mustadiyapanayogabasti and C-Combined Trayodashangaguggulu and 
Mustadiyapana yoga basti for the period of 10 weeks in 30 diagnosed gridhrasi 
patients irrespective of their sex and age group18-60. Results: In group 
A-Trayodashangaguggulu, 50.00% of patients were assessed under improved 
category, 10.00% each were assessed under marked improvement and moder-
ate improvement category and 30.00% showed Unchanged. Nobody included 
under complete relief category. In group B-Mustadiyapana yoga basti, 90.00% of 
patients were assessed under improved category, 10.00% were showed Unchanged. 
Nobody included under complete relief, marked improvement or moderate 
improvement category. In group C-combined therapy of Trayodashangaguggulu 
and Mustadiyapana yoga basti, 50.00% of patients were assessed under moderate 
improvement category, 40.00% were assessed under improved category and 10.00% 
were showed marked improvement category. Nobody included under complete 
relief or unchanged category. ConClusions: Study concluded all the 3 groups 
are effective treatment in Gridhrasi and combined therapy Trayodashangaguggulu 
and Mustadiyapana yoga basti was more effective and showed highly significant 
results in clinical symptoms of Gridhrasi and also provided highly significant 
result in improvingGreenough& Fraser scoring method, SLR test (Straight leg rais-
ing test), Sugar baker &Barofsky clinical mobility scale and Oswestry disability 
assessment questionnaire.
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objeCtives: Cell apoptosis is one of the pathogenesis of osteoporosis. Among a lot 
of medicine, only gallium salts can promote bone formation. The aim of this study 
is to investigate the effect of gallium chloride on apoptosis in osteoporosis rats 
which caused by tretinoin acid. Methods: 67 sprague-Dawley (SD) female rats, 
three months of age, were divided into two groups. 49 rats of model group were 
treated with tretinoic acid for 85mg/ (kg·d) by gavage while 18 rats of normal group 
were treated with distilled water for same amount . All rats were administrated 
for 15 days. After the model has been duplicated successfully, the model group 
rats were divided into three groups: 18 rats of osteoporosis group were treated 
with tretinoic acid for 85mg/ ( kg·d) by gavage, 19 rats of gallium chloride treat-
ment group were administered with gallium chloride 25 mg/( kg·d) by gavage, 12 
rats of estrogen treatment group were give estradiol benzoate (0.2 µg/kg, 3 times 
per week) by intraperitoneal injection. After treatment for 30days, the rats were 
killed. The content of MDA in serum was detected by TBA method. The apoptosis 
of osteocyte was detected by agarose gel electrophoresis. Results: The apoptosis 
ratio of osteocyte in osteoporosis group rats was increased than the other three 
groups while the contents and molecular weight of DNA were decreased. The 
contents of MDA in osteoporosis group rats are significantly increased than the 
other groups. The content of DNA in gallium chloride treatment group rats was 
higher than that of the osteoporosis group rats. ConClusions: Gallium chloride 
can increase the DNA content of bone, through decreasing lipid peroxidation to 
suppress apoptosis of osteocyte.
of everyday life and 17.0% agree with taking these medicines if the person suf-
fers constantly of light mood swings. ConClusions: Survey results suggest 
that stigmatization around schizophrenia and major depression is present in 
Tunisia; there is a great public willingness to help mental disease patients as 
demonstrated by our study. To conclude, raising public awareness in mental health 
could reduce the enormous burden in terms of social functioning in families and 
societies from one side. On the other side, this stigmatization contributes to mar-
ginalize patients, exclude them from health care management and affects their 
disease severity.
PMh36
the uSe of integrAted ConCePt MAPPing to develoP the deMentiA 
CAre Model By CoMMunity PArtiCiPAtion
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objeCtives: The purpose of this study is to develop the dementia care model 
by using integrated concept mapping and community participation. Methods: 
Six health care professionals (1 psychogeriatrician, 1 family physician, 1 resi-
dency, 1 pharmacist, 1 nurse, and 1 physical therapist) and seven non-health 
care professionals (3 village headmen, 2 village health volunteers, and 2 patients’ 
relatives) participated the first meeting conducted by Trochim’s concept map-
ping to generate the ideas then sort and rate the ideas for the feasibility and the 
importance. Later all participants except the psychogeriatrician took part in the 
second meeting conducted by Novak’s concept mapping to name the clusters of 
ideas then re-organised the ideas and added the details to make the complete 
model by the IHMC CmapTools computer programme. Multidimensional scaling 
and hierarchical cluster analysis including quadrant analysis were applied by 
SPSS software. Results: Total 48 ideas of the procedure in the care of dementia 
patient with the Behavioural and Psychological Symptoms of Dementia (BPSD) 
were generated by 12 stakeholders. Trochim’s concept mapping produced 8 
clusters. These eight clusters were labelled as ‘Standards of Care for Dementia’, 
‘Efficient Accessibility System and Continual Care’, ‘Monitoring and Evaluation’, 
‘How to Communicate with Dementia Patients’, ‘Guideline for Family in Dementia 
Management’, ‘Love and Experience Sharing in Dementia Caring Group’, ‘Building 
Generous Communities for Dementia Patients’, and ‘Information Delivery, 
Surveillance, and Cooperation’. Twenty ideas which were highly important and 
highly feasible were selected. Finally, the comprehensive model which has 4 com-
ponents and organised as the procedure in the dementia care with the hospital 
and community involvement was designed. ConClusions: The dementia care 
model originated by hospital staffs who facilitate the community to understand 
and support the family caregivers for the care of dementia patients in the rural 
area with no nursing home. Integrated concept mapping helps to design the appro-
priate model for the real practice.
MuSCulAr-SkeletAl diSorderS – Clinical outcomes Studies
PMS1
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objeCtives: Clinical management of osteoporosis often involves different pharma-
cologic therapies in a sequential manner. Real-world outcomes based on sequential 
treatment in Korea are lacking. Our purpose was to estimate outcomes (fractures, life 
years (LYs), and quality-adjusted life years [QALYs]) for post-menopausal osteoporo-
tic (PMO) women using teriparatide followed by alendronate versus only alendro-
nate. Methods: A validated model of osteoporosis was used to estimate base-case 
outcomes in a cohort of 1,000 severe PMO women (aged 65-90; bone mineral density 
(BMD) T-score of -2.5 standard deviations below young adult mean; 2 prevalent frac-
tures) with 2 years of teriparatide followed by 3 years of alendronate (TPTD2+ALN3) 
compared to 5 years’ alendronate (ALN5). A lifetime horizon was used; 100% therapy 
persistence was assumed. Efficacy values for fracture risk reduction and health utili-
ties were obtained from the literature. Fracture incidence rates were estimated from 
Korean national insurance data (HIRA 2012). Sensitivity analyses were conducted on 
length of treatments and patient risk profiles. Results: In the base case, compared 
to ALN5 the TPTD2+ALN3 cohort had fewer fractures (-174; 4329 vs. 4502), more LYs 
(+32; 8409 vs. 8377), and more QALYs (+74; 5252 vs. 5178). In sensitivity analysis using 
worse BMD T-score of -3.0, the TPTD2+ALN3 cohort had 198 fewer fractures, and 43 
and 92 more LYs and QALYs, respectively, versus ALN5. Assuming longer treatments 
of 7 years of alendronate (ALN7) only and TPTD2+ALN5, the results showed 185 
fewer fractures, 38 more LYs and 83 more QALYs in the TPTD2+ALN5 cohort. In the 
more severe population using a BMD T-score of -3.0, TPTD2+ALN5 vs. ALN7 yielded 
improved outcomes in terms of fewer fractures (-224), and more LYs (+48) and QALYs 
(+104) for the sequential TPTD2+ALN5 cohort. ConClusions: Teriparatide followed 
by alendronate may lead to improved outcomes when compared to alendronate 
only in severe PMO women in Korea.
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objeCtives: Excessive fluoride ingestion causes a disease known as Fluorosis. 
Selenium supplementation could antagonize the bovine fluorosis. So we want 
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Asian men. The extent of causality in these observations is yet to be determined, 
with further prospective cohort studies needed. Nevertheless, these findings high-
light the importance of properly managing patients with these risk factors to 
minimise the risk of fractures.
MuSCulAr-SkeletAl diSorderS – Cost Studies
PMS8
eStiMAting the iMPACt of exPAnding ACCeSS to CeleCoxiB for 
oSteoArthritiS PAtientS in ChinA
Wang B.C.M.1, Xie X.P.2, Furnback W.1
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objeCtives: Currently in China, celecoxib is prescribed to patients with gastro-
intestinal bleeding or perforation history. The aim of this study was to model the 
effect of expanding access to all osteoarthritis (OA) patients in China. Methods: 
We created a one-year budget impact model from a payer perspective comparing 
two scenarios. The first scenario (A) restricts the use of celecoxib to only patients 
with gastrointestinal bleeding or perforation history while the second scenario 
(B) does not restrict usage. In (A), patients were prescribed either diclofenac or 
celecoxib, but those prescribed celecoxib were only dispensed celecoxib if they 
had gastrointestinal bleeding or perforation history. Those prescribed celecoxib 
but not fitting the criteria were dispensed diclofenac. In (B), all prescriptions were 
dispensed as written. For both scenarios, celecoxib and diclofenac prescriptions 
were written 16.2% and 8% of the time, respectively. Patients with gastrointestinal 
bleeding or perforation history made up 5.58% of the OA population. Celecoxib was 
associated with a 20% copay while diclofenac did not have a copay. The base case 
scenario assumes 13,333 patients. Results: Going from (A) to (B), the total cost of 
celecoxib increased ¥2,679,866 (94.42%) while the total cost of diclofenac decreased 
¥1,817,170 (65.66%). The incremental total cost of drugs increased ¥862,697 (29.48%). 
The impact on a payer’s plans for the year was only due to drug costs since the 
cost to administer prior authorization was not considered. The per member per 
month increased ¥0.07 from ¥0.24 to ¥0.32. ConClusions: The expanded access 
scenario (B) resulted in slightly higher drug costs to the payer, which may be accept-
able under most thresholds. Patient outcomes should also be considered to fully 
understand the impact of removing the gastrointestinal bleeding and perforation 
history stipulation.
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objeCtives: To study the current prescription pattern and to analyze the cost 
of the treatment prescribed to RA patients referred to orthopedics OPD in a ter-
tiary care teaching hospital of South India. Methods: The study protocol was 
approved by the institutional ethics committee. Patients attending Orthopedic OPD 
for existing RA disease were recruited as per inclusion criteria. Written informed 
consent was sought. Total 100 consecutive rheumatoid arthritis patients (fulfilling 
the American College of Rheumatology Criteria 1987) were recruited during study 
period. Study Design: Cross-sectional study. Study Duration: 06 Months (From July 
1st to December 31st 2014) Study Site: Department of Orthopedics, Government 
Medical College and Hospital, Anantapuramu, Andhra Pradesh, India. Results: 
Majority of patients (67%) in the study population were on combination of two 
DMARDs. Most frequently prescribed two DMARDs combination was methotrexate 
and hydroxychloroquine (64%). Average total cost per prescription was found to be 
763.39, while average hospital and out of pocket expense were 281.12 and 482.88 
respectively. ConClusions: The drug use pattern in RA was found to be DMARDs 
based and majority of the cost was borne by the patient. The total increase in cost 
was due to administration of drugs to treat the adverse drug reaction. Prospective 
studies in a larger number of patients are needed to assess the utility of prescription 
audit and cost analysis of drugs used in RA.
PMS10
the CoStS of MAjor And Minor CyCling ACCidentS in tASMAniA, 
AuStrAliA
Palmer A.J., Si L., Gordon J.
University of tasmania, Hobart, Australia
objeCtives: To estimate the societal costs of cycling accidents in Tasmania, 
Australia. Methods: Between July 2011 and March 2012, 136 regular cyclists 
completed a telephone-based questionnaire. Information collected included 
demographics, cycling habits and details of major (requiring medical treatment 
or days off work) and minor (not requiring medical treatment or whole days off 
work) cycling accidents. The societal costs of accidents in 2011 Australian Dollars 
($) were estimated from self-reported medical resource consumption and lost work 
and leisure time, combined with published medical resource unit costs and sal-
ary data. Results: Participants reported 59 major accidents in 5 years preceding 
the interview, and 27 minor accidents in the previous 12 months. The mean total 
costs per major accident were $12,158, including direct medical costs $2,228, direct 
non-medical costs $372, resulted in 3.7 days off work equating to indirect costs of 
$6,027 and 54.5 days of lost leisure time equivalent to $3,531. The average costs of 
a minor accident were $632 and included direct non-medical costs of $225, pro-
ductivity losses of $117 and 5.2 days of lost leisure time valued at $290. The total 
annual costs to society of major cycling accidents in Tasmania were estimated 
at $4,123,445. ConClusions: Costs resulting from both minor and major cycling 
accidents are substantial. The costs of improvements to cycling infrastructure/safety 
may be offset by reduced costs to society of cycling accidents.
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objeCtives: To observe the effect of Iguratimod (T-614) on peripheral blood mon-
onuclear cells (PBMCs),Th1 cells and the expression level of IL-8 of rheumatoid 
arthritis (RA) patients, and to explore the possible mechanism of T-614 in treat-
ing RA. Methods: 6 patients were diagnosed with RA referred to Department of 
Rheumatology, The Fifth Hospital of Xi’an. They were evaluated by the score of VAS, 
DAS28 and the response rates of ACR20/70, respectively. PBMC were prepared from 
6 patients in active stage of RA. and treated with T-614 at different concentration 
(lower dose: 100ug/ml; Higher dose: 1mg/ml ) for 1h and 24h. Flow cytometry (FCM) 
were performed to examine the apoptosis of PBMC and the level of IFN-γ secre-
tion by T cells. Results: We found that: We found that: 1) Iguratimod effectively 
induced apoptosis in PBMCs in 1h treatment, T-614 100ug/ml was 19.3±2.8% and 
1mg/ml 26.4±3.1%,(P< 0.05); 2) Compared with control, Iguratimod effectively inhibit 
CD3+ T cell secretion at 24h, T-641(1mg/ml) 1.33±0.12% and control (without T-614) 
2.91±0.13% P< 0.05). 3) Levels of IL-8 in the supernatant of T-614 treated group and 
control group were tested by ELISA, Iguratimod effectively inhibit IL-8 prodcution 
and there were significant differences (P< 0.05). ConClusions: The results suggest 
that T-614 induced PBMC apoptosis and decreasing CD3+ T cell IFN-γ production 
and secretion of IL-8 in peripheral blood might be the possible mechanism of the 
effective of T-614 in treatment of RA.
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objeCtives: The objective of this pilot study was to assess the barriers to the 
treatment of Osteoporosis in post-menopausal women, from both a physician and 
patient perspective. Methods: An open-ended structured survey was conducted 
for Physicians and patients across suburban areas of Mumbai. Questionnaires were 
designed to have questions on incidence of fractures, assessment methods for treat-
ment, treatment regimen, for physicians, and history of fractures and compliance 
to treatment for patients, identified thorough review of the literature. Descriptive 
statistics were performed. Results: As Reported by the Physicians ,85% of the post-
menopausal women had vitamin D deficiency, High Incidence of Bone Fracture (hip) 
were common among 70%of Patients, Preferred Regimen was Calcium Supplement 
(Dietary, Oral dose 500mg twice daily), Multivitamins and/or Bisphosphonates 
with Vitamin D (70mg/5,600U tablet Once weekly). Obstacle to treatment were 
Unavailability of Dual energy X-ray absorptiometry (DEXA) Technology which is 
Gold standard for diagnosing osteoporosis was perceived by 80% of physicians to be 
a barrier for Proper diagnosis. Patients advised for DEXA scan were Non-Compliant 
due to Cost of Diagnosis. Time and Cost of Diagnosing and Patient Reluctance were 
reported by Physicians .Major Reason for Non-Compliance were Cost of Therapy 
as Bisphosphonates are costly compared to vitamin D and calcium as it being not 
included under DPCO along with Poor Patient Counselling. ConClusions: The 
survey gives preliminary evidences that Post-Menopausal Women were Vitamin D 
deficient. Unavailability of DEXA for diagnosis was perceived to be a major barrier 
for treatment .Increased cost of therapy and non-compliance could be undertaken 
by Government initiative to consider Bisphosphonates under DPCO and Provide 
DEXA machines in Hospitals for Free scan. Pharmacist can bridge the gap for poor 
Patient Counselling by educating the patient about importance of Adherence to 
Treatment and Occasional DEXA scan to be done for better monitoring of Bone 
loss/Recovery during Regimen.
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objeCtives: The prevalence of both lifestyle-related metabolic disorders and 
osteoporosis is increasing in Asia. The aim of this systematic review was to sum-
marise all published studies within Asia on the association between disorders of 
glucose and fat metabolism (type 2 diabetes, hyperglycemia, hypercholesterolemia, 
hyperlipidemia, dyslipidemia, metabolic syndrome (MetS) and atherosclerosis) 
and risk of fracture and osteoporosis. The relationship between metabolic dis-
orders and bone mineral density (BMD) was also examined. Methods: EMBASE 
(including MEDLINE) and the Cochrane Library were searched. Only studies con-
ducted within Asia (including East, South-East and South Asia and the Middle-
East), which reported multivariate analysis with a sample size ≥ 200 subjects, 
were included. Results: A total of 33 studies were included, of which 32 were 
assessed as adequate and one high quality based on SIGN criteria. All seven studies 
examining diabetes and fracture found that subjects with diabetes had a higher 
risk of fracture compared with subjects without diabetes (risk estimate range: 
1.26 to 4.73). In contrast, no association was found between diabetes and BMD, 
although a high degree of heterogeneity was observed. Two studies found that 
subjects with atherosclerosis had higher risk of fracture (risk estimate range: 
1.10 to 2.52). Included studies consistently reported that MetS is likely associated 
with osteoporosis or decreased BMD in men but not women. There was limited 
evidence investigating lipid metabolism and hyperglycemia and risk of fracture 
or bone loss. ConClusions: These findings suggest that diabetes is a risk factor 
for fracture in Asian populations. Atherosclerosis may also be associated with 
increased fractures in Asian populations, and MetS associated with bone loss in 
